Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$158M |
| 2 |
Match Group
MTCH
|
+$112M |
| 3 |
Algonquin Power & Utilities
AQN
|
+$62M |
| 4 |
Adobe
ADBE
|
+$51M |
| 5 |
KKR & Co
KKR
|
+$46.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$486M |
| 2 |
PPLI
People Inc
PPLI
|
+$117M |
| 3 |
Microsoft
MSFT
|
+$110M |
| 4 |
Alibaba
BABA
|
+$109M |
| 5 |
Fastly Inc
FSLY
|
+$85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Healthcare | 12.99% |
| 3 | Consumer Discretionary | 12.41% |
| 4 | Financials | 12.09% |
| 5 | Communication Services | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RNAM
2676
DELISTED
Avidity Biosciences
RNAM
| $53K | ﹤0.01% |
+1,871
| New | +$54.1K |
|
|
SVM
2677
Silvercorp Metals
SVM
$2.53B
| $53K | ﹤0.01% |
7,400
+1,920
| +35% | +$14.2K |
|
2678
Viemed Healthcare
VMD
$371M
| $53K | ﹤0.01% |
6,154
-1,438
| -19% | -$14.5K |
|
2679
Astrana Health
ASTH
$1.77B
| $53K | ﹤0.01% |
2,930
+662
| +29% | +$11.4K |
|
|
BSTC
2680
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $53K | ﹤0.01% |
998
-281
| -22% | -$17.3K |
|
2681
BrightView Holdings
BV
$1.07B
| $52K | ﹤0.01% |
4,477
-603
| -12% | -$7.24K |
|
2682
Sterling Infrastructure
STRL
$16.7B
| $52K | ﹤0.01% |
3,618
-1,078
| -23% | -$13.5K |
|
2683
Willdan Group
WLDN
$1.3B
| $52K | ﹤0.01% |
2,011
-449
| -18% | -$12.1K |
|
|
FBMS
2684
DELISTED
The First Bancshares, Inc.
FBMS
| $52K | ﹤0.01% |
2,459
-906
| -27% | -$19.2K |
|
|
AUD
2685
DELISTED
Audacy, Inc.
AUD
| $52K | ﹤0.01% |
31,954
-5,352
| -14% | -$8.01K |
|
|
WTRE
2686
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
| $52K | ﹤0.01% |
2,268
-671
| -23% | -$12.3K |
|
|
BDSI
2687
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $52K | ﹤0.01% |
13,905
-3,711
| -21% | -$15.8K |
|
2688
Financial Institutions
FISI
$821M
| $51K | ﹤0.01% |
3,285
-641
| -16% | -$10.5K |
|
2689
ICICI Bank
IBN
$108B
| $51K | ﹤0.01% |
5,226
-10,348
| -66% | -$103K |
|
2690
iShares Russell 1000 ETF
IWB
$50.1B
| $51K | ﹤0.01% |
275
| – | – |
|
|
ACCD
2691
DELISTED
Accolade Inc
ACCD
| $51K | ﹤0.01% |
+1,310
| New | +$45.2K |
|
|
CDMO
2692
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $51K | ﹤0.01% |
6,750
-2,527
| -27% | -$19.1K |
|
2693
Sierra Bancorp
BSRR
$525M
| $50K | ﹤0.01% |
2,973
-634
| -18% | -$11.4K |
|
2694
Costamare
CMRE
$1.77B
| $50K | ﹤0.01% |
8,364
-2,428
| -22% | -$12.4K |
|
2695
Manchester United
MANU
$3.73B
| $50K | ﹤0.01% |
3,406
| – | – |
|
|
SA
2696
Seabridge Gold
SA
$3.35B
| $50K | ﹤0.01% |
2,649
| – | – |
|
2697
Q32 Bio
QTTB
$464M
| $50K | ﹤0.01% |
259
-79
| -23% | -$17.7K |
|
|
ALBO
2698
DELISTED
Albireo Pharma Inc
ALBO
| $50K | ﹤0.01% |
1,490
-510
| -26% | -$14.9K |
|
|
BNFT
2699
DELISTED
Benefitfocus, Inc.
BNFT
| $50K | ﹤0.01% |
4,528
-1,450
| -24% | -$15.9K |
|
2700
MannKind Corp
MNKD
$1.32B
| $49K | ﹤0.01% |
26,144
-8,900
| -25% | -$15.4K |
|
Similar funds
Legal & General Group's Q3 2020 Portfolio in Review
As of Q3 2020, Legal & General Group held 3,476 positions worth $224B, up 8.1% from $207B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2020: portfolio turnover was 3.2%. Legal & General Group opened 73 new positions and exited 39, leaving the 3,476-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Legal & General Group's largest Q3 2020 buy was AstraZeneca: 305,330 shares worth $33.5M.
- Legal & General Group added most to Zoom in Q3 2020, an estimated $158M increase.
- Legal & General Group's biggest Q3 2020 reduction was Apple, cutting an estimated $486M.
- Legal & General Group fully exited 58.com Inc in Q3 2020, selling an estimated $44.9M.
- Legal & General Group's ten largest holdings make up 22% of its $224B portfolio in Q3 2020.
- Legal & General Group opened 73 new positions and closed 39 in Q3 2020.
- Legal & General Group's portfolio value rose 8.1% quarter-over-quarter to $224B.
Based on Legal & General Group's 13F filing for Q3 2020, filed 13 Nov 2020.